Edward White
Stock Analyst at HC Wainwright & Co.
(1.77)
# 3,293
Out of 4,967 analysts
358
Total ratings
28.66%
Success rate
-9.7%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.69 | +329.13% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $8.26 | +105.94% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $5.97 | +151.26% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $2.10 | +186.40% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.70 | +840.07% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.82 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $8.06 | +892.56% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.40 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $3.11 | +543.09% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.00 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.78 | +323.28% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.27 | +298.72% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.78 | +350.70% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $8.79 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.72 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $29.28 | +87.84% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $16.05 | +217.76% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.13 | +36.45% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $6.68 | +738.32% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.15 | +205.42% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.98 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $7.27 | +9,528.61% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $24.22 | +23.86% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.03 | +1,070.73% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.69
Upside: +329.13%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $8.26
Upside: +105.94%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $5.97
Upside: +151.26%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $2.10
Upside: +186.40%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.70
Upside: +840.07%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.82
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $8.06
Upside: +892.56%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.40
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.11
Upside: +543.09%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.00
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.78
Upside: +323.28%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.27
Upside: +298.72%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.78
Upside: +350.70%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $8.79
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.72
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $29.28
Upside: +87.84%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $16.05
Upside: +217.76%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.13
Upside: +36.45%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $6.68
Upside: +738.32%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.15
Upside: +205.42%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.98
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $7.27
Upside: +9,528.61%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $24.22
Upside: +23.86%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.03
Upside: +1,070.73%